CAMP4 Issuance Of Capital Stock from 2010 to 2025

CAMP Stock  USD 4.91  1.16  30.93%   
CAMP4 THERAPEUTICS Issuance Of Capital Stock yearly trend continues to be relatively stable with very little volatility. Issuance Of Capital Stock is likely to drop to 0.00. During the period from 2010 to 2025, CAMP4 THERAPEUTICS Issuance Of Capital Stock destribution of quarterly values had range of 100.2 M from its regression line and mean deviation of  30,528,164. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
40.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.26, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
  
Check out the analysis of CAMP4 THERAPEUTICS Correlation against competitors.

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.